Following a report in Science that provided data linking CFS to the retrovirus XMRV, in late 2009 the Blood XMRV Scientific Research Working Group was formed by the Department of Health and Human Services to design and carry out a study to determine whether xenotropic murine leukemia virus-related virus (XMRV) posed a threat to blood safety. Drs. Michael Busch, Graham Simmons and Steven Kleinman present the findings from Phase III and discuss their consequences for blood safety and the understanding of this agent's role in CFS.
Link to this comment:
All Comments (0)